Approval · Notice of Compliance 522 · 2004
CLIMARA PRO: Notice of Compliance 522
Issued April 8, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 522
- Date
- April 8, 2004
- Company
- Berlex Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Estrogen + progestin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLIMARA PRO | 02250616 | Cancelled Post Market |
Medicinal ingredients
- ESTRADIOL 4.4 MG per PAD
- LEVONORGESTREL 1.39 MG per PAD